Three New Commercial Health Plans Opt to Cover Myriad’s Prolaris
Prolaris is a genetic test that offers an accurate assessment of how aggressively prostate cancer will progress over the next 10 years.
Read More
Search Results for: genetic testing
Simplexa Congenital CMV Direct Assay Attains CE Mark
The new molecular diagnostic test enables direct detection of cytomegalovirus DNA in both saliva swab and urine specimens from babies up to 21 days old.
Read MorePalmetto GBA Issues Final LCD on Pharmacogenomic Testing for Medicare Beneficiaries
New LCD provides coverage for PGx testing across a broad range of providers and psychiatric conditions.
Read MoreNovel Solution for Accelerated Genomic Diagnosis
Mastermind users now receive more-specific results when searching the comprehensive database of evidence for genomic diagnosis.
Read More
NIH Scientists Develop Blood Test to Help Improve Liver Cancer Screening
A specific viral exposure signature that could accurately distinguish people with HCC from those with chronic liver disease and healthy volunteers.
Read More